Clinical Trial Update: EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache Model [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating an EP4 receptor antagonist with Prostaglandin E2 (PGE2) in a human headache model has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• EP4 receptor antagonist (unspecified)

Snippet

Sponsor: Danish Headache Center | Conditions: Headache, Migraine | Phase 1, Phase 2 | Status: COMPLETED